VILTEPSO: payments to doctors
Payments that named VILTEPSO as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $434K
- Providers
- 725
- Transactions
- 1,737
- Average per transaction
- $250
The per-transaction average — $250 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 725 providers the average total is $598, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| NS Pharma, Inc. | $429,138 | 98.9% |
| Nippon Shinyaku Co.,ltd | $4,572 | 1.1% |